Welcome to the Global Solutions For Infectious Diseases Website
GSID Home Page
About Us
Our Programs
Support GSID
News & Publications
Contact Us

This content has been retired.

For more information about our programs, please click on one of the links below.




Enrollment of volunteers into the PrEPVacc Phase IIb (PV1) clinical trial has started in Uganda. Sites in Tanzania, South Africa and Mozambique to follow soon.